Stock MODTX MODUS THERAPEUTICS HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Modus Therapeutics Holding AB

Equities

MODTX

SE0015987904

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 11:08:54 2024-05-31 am EDT 		5-day change 1st Jan Change
1.075 SEK -2.71% Intraday chart for Modus Therapeutics Holding AB +3.86% -38.04%
May. 14 Modus Therapeutics Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 21 Modus Therapeutics Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2023 2024 2025 2026
Capitalization 1 61.18 62.35 38.63 - -
Enterprise Value (EV) 1 61.18 62.35 37.63 -6.366 31.63
P/E ratio - -1.72 x -2.15 x -1.08 x -1.01 x
Yield - - - - -
Capitalization / Revenue - - - - -
EV / Revenue - - - - -
EV / EBITDA -2.96 x - -2.09 x 0.18 x -0.83 x
EV / FCF - - -2.09 x 0.18 x -0.83 x
FCF Yield - - -47.8% 566% -120%
Price to Book - - -108 x 0.88 x 6.72 x
Nbr of stocks (in thousands) 16,100 35,939 35,939 - -
Reference price 2 3.800 1.735 1.075 1.075 1.075
Announcement Date 2/22/22 2/21/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2023 2024 2025 2026
Net sales 0.002 - - - - -
EBITDA 1 - -20.69 - -18 -36 -38
EBIT 1 - -20.69 - -18 -36 -38
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 - - - -18 -36 -38
Net income 1 -6.019 - -17.9 -18 -36 -38
Net margin -300,950% - - - - -
EPS 2 - - -1.010 -0.5000 -1.000 -1.060
Free Cash Flow 1 - - - -18 -36 -38
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/14/21 2/22/22 2/21/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - - 1 45 7
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - -18 -36 -38
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - - - -0.0100 1.220 0.1600
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 4/14/21 2/22/22 2/21/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODUS THERAPEUTICS HOLDING AB Stock Modus Therapeutics Holding AB
-38.04% 3.67M
MODERNA, INC. Stock Moderna, Inc.
+43.36% 54.64B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 39.92B
LONZA GROUP AG Stock Lonza Group AG
+37.52% 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 11.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MODTX Stock
  4. Financials Modus Therapeutics Holding AB